Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0001415889-24-022856 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Paolini John F. | Chief MEDICAL Off | F - Tax | $26.74 | -2,829 | 52.0K | -5% | -$75.6K |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $1.88 | +66.5K | 112.3K | +146% | +$124.8K |
| DM | 2024-09-04 | 2024-09-03 | KNSA | Paolini John F. | Chief MEDICAL Off | S - Sale+OE | $26.12 | -60.7K | 52.0K | -54% | -$1.58M |
| DM | 2024-09-04 | 2024-09-01 | KNSA | Paolini John F. | Chief MEDICAL Off | A - Grant | $0.00 | +43.4K | 36.4K | New | $0 |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $0.00 | -66.5K | 4,872 | -93% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2024-09-01 | F | D | 1,994 | $26.74 | 51,148 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2024-09-02 | M | A | 1,725 | — | 52,873 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 3 | Common | Class A Ordinary Share | 2024-09-02 | F | D | 835 | $26.74 | 52,038 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2024-09-03 | M | A | 475 | $3.80 | 112,730 | D | — | — | |
| 5 | Common | Class A Ordinary Share | 2024-09-03 | S | D | 59,214 | $26.09 | 53,516 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $25.88 to $26.82. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 6 | Common | Class A Ordinary Share | 2024-09-03 | S | D | 1,478 | $27.13 | 52,038 | D | — | — | (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $26.995 to $27.18. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 7 | Common | Class A Ordinary Share | 2024-09-01 | M | A | 4,121 | — | 53,142 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 8 | Common | Class A Ordinary Share | 2024-09-03 | M | A | 60,217 | $1.86 | 112,255 | D | — | — | |
| 9 | Derivative | Restricted Share Unit | 2024-09-01 | A | A | 7,000 | $0.00 | 7,000 | D | — · — to — | 7,000 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F5) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024. |
| 10 | Derivative | Share Option | 2024-09-01 | A | A | 36,350 | $0.00 | 36,350 | D | $26.74 · — to 2034-08-31 | 36,350 Class A Ordinary Share | (F6) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024. |
| 11 | Derivative | Restricted Share Unit | 2024-09-01 | M | D | 2,497 | $0.00 | 4,995 | D | — · — to — | 2,497 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F7) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. |
| 12 | Derivative | Share Option | 2024-09-03 | M | D | 475 | $0.00 | 44,549 | D | $3.80 · — to 2027-06-28 | 475 Class A Ordinary Share | (F10) The option is fully vested and exercisable. |
| 13 | Derivative | Restricted Share Unit | 2024-09-02 | M | D | 1,725 | $0.00 | 1,725 | D | — · — to — | 1,725 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F9) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021. |
| 14 | Derivative | Share Option | 2024-09-03 | M | D | 60,217 | $0.00 | 0 | D | $1.86 · — to 2026-09-13 | 60,217 Class A Ordinary Share | (F10) The option is fully vested and exercisable. |
| 15 | Derivative | Restricted Share Unit | 2024-09-01 | M | D | 1,624 | $0.00 | 4,872 | D | — · — to — | 1,624 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F8) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023. |